Hoth是一家生物制药商，专注于为未满足的医疗需求开发新一代疗法。Hoth的管道开发专注于改善患有特应性皮炎、癌症治疗相关的皮肤毒性、慢性伤口、牛皮癣、哮喘、痤疮和肺炎等适应症的患者的生活质量。Hoth还签署了两项不同协议，以进一步开发预防或治疗 ...

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a ...

Patients will be able to enroll in trial at any time and regardless of failure from other therapeutics This is a randomized, double-blind, placebo-controlled, multi-center Phase 2a dose-ranging study ...

NEW YORK, June 18, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on breakthrough therapies, today announced that it has regained full ...

Chinese Patent Approved Covering HT-KIT Technology Designed to Induce Cancer Cell Apoptosis, Expanding Protection in One of the World's Largest Oncology Markets NEW YORK, Jan. 21, 2026 /PRNewswire/ -- ...